AD affects approximately 60–70% of dementia patients and is characterized by progressive memory decline, amyloid-β (Aβ) and tau accumulation, and widespread cortical atrophy (Dubois et al., 2007; Scheltens et al., 2021). This evidence concerns the gene MAPT and Alzheimer disease.